Biotech Cannabis Stocks
Biotech cannabis companies focus on pharmaceutical research and development of cannabinoid-based medicines. These companies pursue FDA approval for cannabis-derived treatments.
4 stocks found · Read the full analysis →
| # | Company | Price | Change % | Market Cap | Volume | Sector |
|---|---|---|---|---|---|---|
| 1 | JAZZJazz Pharmaceuticals | $227.32 | ▼-3.13% | $14.77B | 671.0K | Biotech |
| 2 | INNPFInnocanPharma | $1.29 | ▲+0.00% | $93.1M | 0 | Biotech |
| 3 | BHSTBioHarvest Sciences | $1.49 | ▲+2.05% | $35.2M | 131.0K | Biotech |
| 4 | XXII22nd Century Group | $1.93 | ▼-20.77% | $23.5K | 349.8K | Biotech |
More Screeners
Browse Screens
Explore our pre-built stock screens to quickly find cannabis stocks matching specific criteria.
Stocks Under $1Stocks Under $5Stocks Under $10Stocks Under $20Cannabis Penny StocksLarge CapMid CapSmall CapMicro CapProfitable StocksHigh VolumeRevenue GrowthHigh Growth (20%+)Low DebtBest Gross MarginsHighest RevenueMost EmployeesNear 52-Week LowNear 52-Week HighMSO StocksLP StocksAncillary StocksBiotech StocksREIT StocksNASDAQ ListedNYSE ListedOTC ListedUS CompaniesCanadian Companies